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A B S T R A C T   
Endothelial dysfunction, with impaired bioavailability and/or bioactivity of the vasoprotective molecule, nitric 
oxide, appears to be a vital step in the initiation of atherosclerosis. Several studies have shown that dietary 
nitrate/nitrite can have significant benefits on human cardiovascular homeostasis. Although serum nitrite con-
centrations can reach micromolar levels, the physiological significance of nitrate/nitrite in normal tissues has not 
been fully elucidated. We investigated in vitro the chronic effects of nitrate/nitrite on endothelial nitric oxide 
synthase (eNOS) to determine the potential vasoprotective effects of nitrate/nitrite and the underlying molecular 
mechanisms. Our results demonstrate the expression of phosphorylated eNOS at Ser1177 and phosphorylated 
adenosine monophosphate activated protein kinase (AMPK) at Thr172 in human aortic endothelial cells were 
increased after nitrite treatment. We suggest that nitrite stimulation may enhance eNOS activation, which is due, 
in part, to AMPK activation. The AMPK–eNOS activation by nitrite may be a possible molecular mechanism 
underlying the vascular protective effects of dietary nitrate.   
1. Introduction 
Cardiovascular disease (CVD) is the leading cause of mortality 
worldwide (Roth et al., 2017). The aetiology and pathogenesis of CVD is 
multifactorial, including genetic, environmental, dietary and lifestyle 
factors (Balakumar, Maung, & Jagadeesh, 2016). Major adverse events 
of CVD, such as myocardial infarction and stroke, are predominately due 
to reduced and ultimately blocked blood flow in the corresponding tis-
sues and organs. This arises secondary to a thickening of the inner layer 
of arteries and the formation of obstructive atherosclerotic plaques, 
which can impede flow or dislodge and travel elsewhere to block blood 
flow (Gimbrone & Garcia-Cardena, 2016). Endothelial dysfunction is 
characterised by disturbed vasodilator and anticoagulant function, 
increased inflammation and breakdown of barrier function, a vital step 
in the initiation of atherosclerosis (Gimbrone & Garcia-Cardena, 2016; 
Vanhoutte, Shimokawa, Tang, & Feletou, 2009). 
Endothelium-derived nitric oxide (NO) is an important signalling 
molecule and is involved in the regulation of cardiovascular homeostasis 
(Daiber et al., 2019). NO is a potent vasodilator, it inhibits platelet 
activation and aggregation, prevents leucocyte adhesion and migration, 
decreases smooth muscle cell proliferation and migration, and sup-
presses oxidation of LDL (Cahill & Redmond, 2016). Reduced NO 
availability is considered the major cause of endothelial dysfunction. In 
the artery wall, NO deficiency activates a series of atherogenic processes 
involving: vasoconstriction, adhesion, migration and differentiation of 
monocytes, proliferation of smooth muscle cells, thrombosis and 
impaired coagulation, and eventually atherosclerosis (Versari, Daghini, 
Virdis, Ghiadoni, & Taddei, 2009). 
Endothelial nitric oxide synthase (eNOS) is constitutively expressed 
in endothelial cells. It converts the amino acid L-arginine into L-citrulline 
and NO (Bondonno, Croft, Ward, Considine, & Hodgson, 2015). eNOS 
activity is intimately regulated by protein phosphorylation, which is 
modulated by kinases, phosphatases and protein–protein interactions 
(Kolluru, Siamwala, & Chatterjee, 2010). Phosphorylation of eNOS oc-
curs on threonine, tyrosine residues, as well as serine 1177 (Ser1177) in 
the reductase domain (Mount, Kemp, & Power, 2007). eNOS is directly 
regulated by protein kinase B (Akt) in endothelial cells in response to a 
variety of cellular stimuli. Activation of Akt at Ser473 leads to eNOS 
* Corresponding author at: Medical School, University of Western Australia, Rear 50 Murray Street, Perth, WA 6000, Australia. 
E-mail address: natalie.ward@uwa.edu.au (N.C. Ward).  
Contents lists available at ScienceDirect 
Journal of Functional Foods 
journal homepage: www.elsevier.com/locate/jff 
https://doi.org/10.1016/j.jff.2021.104447 
Received 4 September 2020; Received in revised form 2 March 2021; Accepted 10 March 2021   
Journal of Functional Foods 80 (2021) 104447
2
phosphorylation, thereby enhancing eNOS activity, and consequently 
increasing NO generation (Sessa, 2004). Metabolic stress can also trigger 
the breakdown of ATP, which can stimulate adenosine monophosphate- 
activated protein kinase (AMPK) to phosphorylate eNOS (Michell et al., 
2002; Sessa, 2004). 
Inorganic nitrate and nitrite from endogenous and dietary sources 
are emerging as an alternative pathway for NO generation, especially 
when the nitric oxide synthase (NOS) pathway is compromised (Lund-
berg, Weitzberg, & Gladwin, 2008; Machha & Schechter, 2011). In the 
human body, absorbed dietary nitrate is efficiently converted into nitrite 
by commensal facultative anaerobic bacteria, and subsequently nitrogen 
oxides including NO is formed through reduction of nitrite (Lundberg 
et al., 2008). It has been suggested that the nitrate–nitrite–NO pathway 
may be critical in maintaining bioactive NO levels and might play a key 
role in maintaining cardiovascular homeostasis (Bondonno, Croft, & 
Hodgson, 2016). 
eNOS is a major contributor to bioactive NO generation and main-
tains cardiovascular homeostasis. However, the interactions between 
nitrate/nitrite and eNOS under physiological conditions have not been 
clarified to date. We hypothesized that eNOS exerts a significant action 
in the nitrate-nitrite-NO pathway under normoxic conditions. We 
investigated the effects in vitro of chronic treatment with nitrate and 
nitrite on eNOS and associated molecules in human aortic endothelial 
cells (HAECs) to determine potential molecular mechanisms underlying 
the beneficial effects of nitrite and nitrate. 
2. Materials and methods 
2.1. Cell cultures and stimulations 
HAECs (Lonza Pty Australia) were cultured in commercially avail-
able EBM-2 media (Lonza Pty Australia) containing 10% Foetal Bovine 
Serum (Corning) in T-75 tissue culture flasks (Thermo Fischer Scientific, 
USA). Cells were grown at 37℃ with 5% CO2 and 18.6% O2 in a hu-
midified incubator and maintained in a logarithmic growth phase by 
routine passages every 2–3 days at a 1:3 split ratio. All experiments were 
performed with cells from passage three to nine in 6-well culture plates 
(Thermo Fischer Scientific, USA). 
The cells were maintained in regular media prior to all experiments. 
Following a 4 hr serum starvation, the cells were treated with sodium 
nitrite (NaNO2) (final concentration of 0.1 µM and 1 µM) or sodium ni-
trate (NaNO3) (final concentration of 1 µM and10 µM) for 30 min or 24 
hr. To assess the contribution of eNOS on the response to NaNO2, cells 
were pre-incubated with 100 µM N (gamma)-nitro-L-arginine methyl 
ester (L-NAME, NOS inhibitor) for 30 min. The role of AMPK in modu-
lating eNOS activation was determined by incubation with 20 µM 
Compound C (AMPK inhibitor) or 1.25 mM 5-Aminoimidazole-4-car-
boxamide ribonucleotide (AICAR, AMPK activator) for 1 hr. At the 
end of the treatment periods, cell lysates were collected and stored at 
− 80 ℃ until further analysis. 
2.2. Immunoblotting 
The cells were washed twice with ice-cold PBS then lysed and har-
vested in 200 ml Laemmli’s SDS-sample buffer (Bio-Rad, Australia), 
containing 250 mM Tris-HCl, 8% SDS, 40% glycerol, 8% β-mercaptoe-
thanol, 0.02% bromophenol blue, 5% 2-mercaptoethanol and a phos-
phatase inhibitor cocktail (Roche Diagnostics, Australia). Thirty 
micrograms of protein per sample was subjected to sodium dodecyl 
sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) using 4%–10% 
polyacrylamide gels (Bio-Rad, Australia), and transferred onto a nitro-
cellulose membrane (GE Healthcare Life Sciences, USA) overnight at 
4℃. The membranes were blocked with 5% skim milk for 1 hr at room 
temperature and probed with primary antibody overnight at 4℃ (1:500 
or 1:1000). Membranes were washed in Tris-buffered saline containing 
0.1% Tween followed by incubation with HRP-conjugated secondary 
antibodies (1:5000) at room temperature for 1 hr. Proteins were visu-
alized using the enhanced chemiluminescence kit (Thermo Fischer Sci-
entific, USA) under a ChemiDoc XRS system (Bio-Rad). Protein bands 
were analysed using the image lab software (Bio-Rad) and normalized to 
the parent protein or Pan-actin. 
2.3. Antibodies and chemicals 
Antibodies for AKT (#4691), p-AKTSer473 (#4060), AMPKα (#2603), 
p-AMPKThr172 (#2535), ACC (#3676), p-ACCSer79 (#3661), Pan-Actin 
(#4968) and p-eNOSSer1177 (#9571) were purchased from Cell Signal-
ling Technologies (Denvers, MA, USA). Antibodies for eNOS (#610298) 
was purchased from BD Biosciences (San Jose, CA, USA). NaNO2, 
NaNO3, potassium iodide, iodine, Compound C, L-NAME and AICAR 
were purchased from Sigma-Aldrich (St. Louis, MO, USA). Other re-
agents were obtained from RPH Medical Research Foundation. Stock 
solutions of NaNO2 (20 mM) and NaNO3 (20 mM) were prepared with 
fresh Milli-Q water. 
2.4. Statistics 
All immunoblots shown are the representative results from 4 inde-
pendent experiments. Values are presented as means ± SEM. Compari-
sons between groups were performed by one-way ANOVA followed by 
Tukey–Kramer or Dunnett’s post-hoc test. A value of p < 0.05 was 
considered statistically significant. All analyses were carried out using 
the GraphPad Prism 7. 
3. Results 
3.1. Effects of nitrite and nitrate on eNOS phosphorylation in HAECs 
To confirm eNOS is involved in the actions of nitrite and nitrate, we 
determined the level of phosphorylated eNOS at Ser1177. Following 
nitrite treatment for 24 hr, the expression of p-eNOS was significantly 
increased (Fig. 1). In contrast, treatment of HAECs with nitrate did not 
alter the ratio of phosphorylated eNOS/total eNOS (data not shown). 
And the level of phosphor-eNOS (Ser 1177) in HAEC stimulated by so-
dium nitrate or nitrite for 30 min was not changed (data not shown). To 
further confirm the role of eNOS activation, we treated cells with nitrite 
in the presence of L-NAME and saw significant reductions in p-eNOS 
(Fig. 2). 
3.2. Nitrite stimulation induces AMPK activation without Akt activation 
As AMPK activation is known to contribute to eNOS phosphorylation 
and activation in endothelial cells, we compared the phosphorylation of 
AMPK in response to nitrite treatment and observed a significant in-
crease in the level of AMPK phosphorylation at Thr172 (Fig. 3). This also 
resulted in an increase in eNOS phosphorylation (Fig. 3) and acetyl-CoA 
carboxylase (ACC) Ser79 phosphorylation (Fig. 3). In contrast, the level 
of phosphorylated Akt was not significantly increased following nitrite 
treatment (Fig. 3). 
3.3. AMPK lies upstream to the eNOS activation 
Compound C, as an inhibitor of AMPK, was used to verify whether 
AMPK lies upstream of the eNOS nitrite interaction. The effects of nitrite 
on the phosphrylation of AMPK and eNOS were both almost completely 
abolished in the presence of Compound C (Fig. 4), suggesting AMPK 
activation takes place first. 
4. Discussion 
NO is one of the most important biological mediators involved in 
maintaining vascular homeostasis. In addition to its ability to influence 
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basal vascular tone, NO is also recognized as a key determinant of 
vascular health by modulating platelet-endothelial interactions, exert-
ing antithrombotic, and anti-inflammatory properties within the 
vasculature. Impaired NO bioavailability represents the central feature 
of endothelial dysfunction, a common abnormality found in many 
vascular diseases. Atherosclerosis, hypercholesterolemia, hypertension, 
diabetes mellitus, thrombosis and stroke have all been linked to ab-
normalities in NO signaling (V. W. T. Liu & Huang, 2008). There are two 
major pathways for the NO formation in the body—the endogenous 
NOS-dependent system and the exogenous nitrate-nitrite-NO pathway 
from dietary uptake of green leafy vegetables (Blekkenhorst et al., 2018; 
Bondonno et al., 2016). The dietary pathway is considered a NO reser-
voir, which contributes to overall NO availability (Milsom, Fernandez, 
Garcia-Saura, Rodriguez, & Feelisch, 2012). Dietary nitrate is converted 
to nitrite by anaerobic bacteria in the mouth. The nitrite anion is a cell- 
signaling molecule, which is considered as a storage pool of NO (Y. Liu, 
Croft, Hodgson, Mori, & Ward, 2020). Once formed, nitrite can be uti-
lized via various nonenzymatic and enzymatic pathways and converted 
to bioactive NO in the circulatory system and tissues (Kim-Shapiro & 
Gladwin, 2014; Weitzberg, Hezel, & Lundberg, 2010). Under hypoxic 
conditions, nitrite may serve as a substrate for endothelium-derived 
generation of NO (Gautier, van Faassen, Mikula, Martasek, & Slama- 
Schwok, 2006). Here, we suggest a possible new way that diet derived 
nitrate/nitrite can activate eNOS in normoxic conditions, with nitrite 
increasing eNOS phosphorylation in cultured HAECs. This finding is 
consistent with a previous report showing eNOS phosphorylation in 
response to treatment with sodium nitrite (Ling, Lau, Murugan, Van-
houtte, & Mustafa, 2015). 
We used HAECs as a cell model and observed that 0.1 μM to 1 μM 
nitrite treatment for 30 min did not significantly change AMPK 
phosphorylation and eNOS activation (data not shown). However, with 
a prolonged treatment (24 hr), we demonstrated that nitrite activates 
AMPK and eNOS. In contrast, a previous study showed that 30 min ni-
trite treatment stimulates eNOS phosphorylation in an AMPK dependent 
manner in human glomerular endothelial cells (HGEC) (Miyamoto et al., 
2017). However, that study used a higher nitrite concentration (10 μM) 
and a different cell line (Miyamoto et al., 2017). The physiological 
concentration of nitrite in blood is likely<1 μM (Gladwin et al., 2000). 
AMPK is an important monitor of cellular metabolism and energy 
homeostasis and regulates almost all aspects of cellular function, 
including autophagy, mitochondrial homeostasis, cell polarity, cell 
growth and cell proliferation (Hardie, 2011; Mihaylova & Shaw, 2011). 
In addition to being activated in response to stimuli that deplete cellular 
ATP supplies, including oxidative stress, nutrient deprivation or hyp-
oxia, AMPK can also be stimulated following exposure to shear stress, 
growth factors, and cytokines (Fisslthaler & Fleming, 2009). In mam-
mals, AMPK is a heterotrimeric complex composed of a catalytic subunit 
(α), and two regulatory subunits (β and γ) (Hardie, 2007). Phosphory-
lation of Thr172, which lies in the activation loop of the α-subunit is 
required for AMPK activation (Stein, Woods, Jones, Davison, & Carling, 
2000). During the last decade, a number of upstream kinase activities 
have been identified (Mihaylova & Shaw, 2011). Among them, calcium/ 
calmodulin-dependent protein kinase kinase (CAMKK) and liver kinase 
B1 (LKB1) are now widely accepted to be the predominant AMPK up-
stream kinases (Carling, Sanders, & Woods, 2008). Previous studies have 
shown that both LKB 1 and CAMKK exist in endothelial cells and mediate 
AMPK activation under different conditions (Stahmann, Woods, Carling, 
& Heller, 2006). In vitro studies have demonstrated that activated AMPK 
can prevent oxidative stress injury in HAECs via increased phosphory-
lation of eNOS at Ser1177 (Li, Reif, Craige, Kant, & Keaney, 2016). A 
Fig. 1. The expression and activity of eNOS in HAECs treated with sodium nitrite (0.1 µM and 1 µM, 24hr). (A) Western blot protein expression of total eNOS, eNOS 
phosphorylation (Ser1177) and Pan-actin in HAECs. (B) The expression level of p-eNOS and eNOS was measured by the densitometry of the corresponding bands and 
normalised to Pan-actin using Image Lab. Values are means ± SEM, n = 4/group, *p < 0.05 vs control. p-eNOS: phosphorylated endothelial nitric oxide synthase; 
eNOS: endothelial nitric oxide synthase; HAECs: human aortic endothelial cells. 
Fig. 2. The expression and activity of eNOS in HAECs treated with sodium nitrite (1 µM, 24hr) in the presence and absence of L-NAME (100 µM). (A) Western blot 
protein expression of total eNOS, phosphorylated eNOS (Ser1177) and Pan-actin in HAECs. (B) The density of the western blotting band analyzed by Image Lab. 
Values are means ± SEM, n = 4/group, *p < 0.05 vs control, #p < 0.05 presence of inhibitor vs respective treatment. p-eNOS: phosphorylated endothelial nitric oxide 
synthase; eNOS: endothelial nitric oxide synthase; HAECs: human aortic endothelial cells; L-NAME: N-Nitroarginine methyl ester. 
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recent study has shown that nitrite restored phosphorylated AMPK 
levels in steatosis HepG2 cells (Cordero-Herrera et al., 2019). This 
supports our present findings, where we saw increased AMPK 
phosphorylation at significantly lower doses of nitrite, in a human cell 
line that is more directly related to cardiovascular disease. Prolonged 
supplementation with 10 μM nitrite can also increase activation of 
Fig. 3. The expression and activity of Akt, AMPK and in HAECs treated with sodium nitrite (0.1 µM and 1 µM, 24hr). (A) Western blot protein expression of total 
AMPK, phosphorylated AMPK (Thr172), total Akt, phosphorylated Akt (Ser473), total ACC and phosphorylated ACC (Ser79) and in HAECs. (B) The density of the 
western blotting band analyzed by Image Lab. Values are expressed as means ± SEM, n = 4/group, *p < 0.05 vs control. p-Akt: phosphorylated Protein kinase B; Akt: 
Protein kinase B; p-AMPK: phosphorylated 5′ adenosine monophosphate-activated protein kinase; AMPK: 5′ adenosine monophosphate-activated protein kinase; p- 
ACC: phosphorylated acetyl-CoA carboxylase; ACC: acetyl-CoA carboxylase; HAECs: human aortic endothelial cells. 
Fig. 4. The expression and activity of phosphorylated AMPK and phosphorylated eNOS in HAECs treated with sodium nitrite (1 µM, 24hr) in the presence and 
absence of AICAR (AMPK activator, 1.25 mM) or Compound C (20 µM). (A) Western blot protein expression of total AMPK, phosphorylated AMPK (Thr172), total 
eNOS and phosphorylated eNOS (Ser117) in HAECs. (B) The density of the western blotting band analyzed by Image Lab. Valures are expressed as means ± SEM, 
n = 4/group, *p < 0.05 vs control, #p < 0.05 presence of inhibitor vs respective treatment. p-eNOS: phosphorylated endothelial nitric oxide synthase; eNOS: 
endothelial nitric oxide synthase; p-AMPK: phosphorylated 5′ adenosine monophosphate-activated protein kinase; AMPK: 5′ adenosine monophosphate-activated 
protein kinase; HAECs: human aortic endothelial cells; AICAR: 5-Aminoimidazole-4-carboxamide ribonucleotide; Compound C: dorsomorphin. 
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AMPK in insulin-resistant human skeletal muscle cells (Lai et al., 2016). 
It has also been reported that AMPK can be activated to stimulate 
mitochondrial biogenesis in response to nitrite exposure (50 μM, 3hr) in 
rat aortic smooth muscle cells under hypoxic conditions (Mo et al., 
2012). The protection mediated by nitrite and thought to be dependent 
on AMPK activation is optimized under the conditions of anoxia and low 
pH. In addition, nitrite not only confers cardioprotection when admin-
istered during ischaemia, but also when transiently present hours prior 
to the onset of an ischaemic episode (Kamga Pride et al., 2014). 
Consistent with our results, nitrite activates AMPK in normoxia, but the 
underlying mechanisms are unclear. When intracellular ATP is low, 
AMPK might be activated by both LKB1 and CAMKK. As a result, acti-
vated AMPK mediates eNOS activation in a LKB1 dependent manner 
(Thors, Halldorsson, & Thorgeirsson, 2011). Conversely, under condi-
tions where intracellular ATP is unchanged, there is less NO generation 
and activation of AMPK is only dependent on CAMKK. Thus eNOS is 
phosphorylated and activated independently of AMPK (Thors et al., 
2011). Although we did not measure ATP concentration in culture 
media, it may be speculated that ATP levels will be decreased by nitrite 
stimulation over time. Thus, it is likely that eNOS phosphorylation is 
AMPK dependent and this is supported by the fact that the activation of 
AMPK and eNOS were almost completely abolished by treatment with 
Compound C. Unfortunately due to the gas phase chemilluminescence 
methodology used to measure NOx we were unable to confirm increased 
NO production in our study as the concentration of NOx measured in the 
culture media also included the nitrite which was added to the cells 
(data not shown). 
It is well-established that the phosphatidylinositol 3-kinase (PI3K)– 
Akt cascade is a commonly activated signalling pathway that regulates 
eNOS activation in endothelial cells (Fleming & Busse, 2003). eNOS Ser 
1177 has been shown to be phosphorylated by Akt as well as AMPK 
(Zhang et al., 2009). However, Akt is unlikely to promote eNOS acti-
vation mediated by nitrite, as no significant change in Akt phosphory-
lation levels was detected following nitrite treatment. Therefore, nitrite 
is proposed to mediate eNOS activation in an AMPK-dependent, but not 
Akt-dependent manner. AMPK’s role as an energy sensor has been well 
established in many tissues and organs such as the skeletal muscle and 
heart. However, its exact role in endothelial cell metabolism remains 
incompletely understood. It is believed that endothelial cells exist in a 
more or less permanent state of “metabolic hypoxia” (Fisslthaler & 
Fleming, 2009) and AMPK may have a more important role in the 
maintenance of endothelial function. AMPK is the only kinase identified 
to date that can potentially phosphorylate eNOS on Ser633 (Chen et al., 
2009) which might be more efficacious than Ser1177 in augmenting the 
eNOS-derived NO bioavailability (Bauer et al., 2003). Furthermore, 
phosphorylation of Ser633 seems to occur after eNOS Ser1177 phos-
phorylation, where this post-translational modification of Ser633 is 
proposed to maintain persistent eNOS activity after its initial activation 
(Boo et al., 2002). Future investigation is needed to clarify whether 
phosphorylation of Ser633 is stimulatory for eNOS activity by nitrite 
stimulation. 
In conclusion, we have shown that nitrite at physiological concen-
trations is an activator of the AMPK–eNOS pathway in human aortic 
endothelial cells. Nitrite, may increase NO production via activating 
AMPK, followed by eNOS activation in addition to non-enzymatic 
pathway as previously reported. The AMPK–eNOS activation by nitrite 
could be a potential molecular mechanism underlying the car-
dioprotective effects of dietary nitrate. 
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